neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 21 (7) , 750-758
- https://doi.org/10.1016/0046-8177(90)90035-4
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancerInternational Journal of Cancer, 1988
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- c-erbB-2 expression in benign and malignant breast diseaseBritish Journal of Cancer, 1988
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.Molecular and Cellular Biology, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF ReceptorScience, 1985